Liver Biopsy
Care Before the Procedure
- Pre-Procedure Evaluation:
- Blood tests (coagulation profile, platelet count) to ensure safe biopsy conditions.
- Imaging (ultrasound/CT) to map liver anatomy and identify the optimal biopsy site.
- Review of medications (discontinue blood thinners like warfarin, clopidogrel, or NSAIDs 5–7 days prior).
- Fasting:
- No food or drink for 6–8 hours before the procedure to reduce aspiration risk and ensure an empty stomach.
- Consent and Education:
- Discussion of risks (bleeding, pain, rare organ injury) and benefits.
- Arrangements for a companion to drive the patient home post-procedure.
Care During the Procedure
- Setting: Performed in a hospital or outpatient procedure room.
- Approaches:
- Percutaneous Biopsy: Most common. The patient lies on their back with the right arm raised. Local anesthesia is applied, and a needle is inserted between the ribs into the liver.
- Transjugular Biopsy: Used for high bleeding risk patients. A catheter is threaded through the jugular vein to the liver veins to collect tissue.
- Duration: 15–30 minutes for percutaneous biopsy; longer for transjugular approach.
- Patient Experience:
- Local anesthesia minimizes pain at the insertion site.
- Pressure or dull pain may be felt as the needle enters the liver.
- Sedation may be offered for anxious patients.
Care After the Procedure
- Immediate Recovery:
- Lie on your right side for 2–4 hours to apply pressure on the biopsy site and reduce bleeding risk.
- Monitor vital signs (blood pressure, heart rate) for several hours.
- Discharge same day if no complications arise.
- Activity Restrictions:
- Avoid strenuous activity, heavy lifting, or exercise for 5–7 days.
Resume normal activities gradually as tolerated.
- Avoid strenuous activity, heavy lifting, or exercise for 5–7 days.
- Symptoms to Report Immediately:
- Severe right shoulder or abdominal pain.
- Dizziness, fainting, or rapid heart rate.
- Fever, chills, or worsening redness/swelling at the biopsy site.
- Results:
- Tissue samples are sent to pathology; results typically available in 5–10 days.
- Follow-up with the referring physician to discuss findings and treatment plan.
- Long-Term Monitoring:
- Repeat biopsies may be needed to assess treatment response or disease progression.
- Integrate results with ongoing management (e.g., lifestyle changes for fatty liver, medications for hepatitis).
- Note: Liver biopsy remains the gold standard for diagnosing many liver diseases despite advances in non-invasive tests (e.g., FibroScan). While generally safe, it requires an experienced operator and careful patient selection to minimize risks. Always follow pre- and post-procedure instructions closely to ensure optimal safety and accuracy.
Eligibility
- A liver biopsy may be recommended for patients with:
- Persistently elevated liver enzymes (ALT, AST) without a clear cause.
- Unexplained jaundice, liver enlargement, or portal hypertension.
Suspected advanced fibrosis or cirrhosis. - Liver masses or lesions seen on imaging that require characterisation.
- Systemic diseases with potential liver involvement (e.g., sarcoidosis, amyloidosis).
- Post-liver transplant monitoring for rejection or recurrence of disease.
- Pre-Procedure Evaluation:
- Blood tests (coagulation profile, platelet count) to ensure safe biopsy conditions.
- Imaging (ultrasound/CT) to map liver anatomy and identify the optimal biopsy site.
- Review of medications (discontinue blood thinners like warfarin, clopidogrel, or NSAIDs 5–7 days prior).
- Fasting:
- No food or drink for 6–8 hours before the procedure to reduce aspiration risk and ensure an empty stomach.
- Consent and Education:
- Discussion of risks (bleeding, pain, rare organ injury) and benefits.
- Arrangements for a companion to drive the patient home post-procedure.
More from KIMSHEALTH
